Healthcare IT News May 11, 2020
Nathan Eddy

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “advanced discussions” to step down from the role, according to a Dow Jones report.

WHY IT MATTERS
Dr. Gawande, a surgeon and Harvard professor, was tapped to lead the then-unnamed joint venture nearly two years ago in 2018. Haven’s much-publicized debut positioned it as a disruptive force in the healthcare industry that would harness technology to lower costs...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Self-insured
H.R.1 Threatens The Stability Of Medicaid Managed Care
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
How To Keep Competition Alive In Medicaid Managed Care Markets
Fortifying Medicaid Managed Care for Postpartum Enrollees: The Clearest Path to Improving Maternal Health
UnitedHealth Group's earnings reflect industry-wide pressure

Share Article